Saratov JOURNAL of Medical and Scientific Research

The role of mTOR in reprogramming of tumor associated macrophages and in cancero-genesis (review)

Year: 2020, volume 16 Issue: №1 Pages: 115-121
Heading: Рathophysiology Article type: Review
Authors: Martynova T.N., Malyshev I.Yu.
Organization: A. I. Yevdokimov Moscow State University of Medicine and Dentistry, Institute of General Pathology and Pathophysiology

Macrophages are heterogeneous population of cells, which differentiate into distinct functional groups depending of the external signals. Agonists of toll-like receptors (TLRs) and cytokines bind to corresponding receptors and cause changes in the metabolism and expression of genes in myeloid cells located in the innate immune system. These changes in phagocytes are occurring during their activation. As a result, they become polarized, acquiring a determined phenotype. This gene expression changes realize in the tumor microenvironment. mTOR — serine/threonine protein kinase, which receives various signals from cell environment. It causes changes in protein biosynthesis and cell metabolism. mTOR takes part in the activation of macrophages influenced by cytokines or agonists of TLRs. It determines the role of kinase in reprogramming mechanisms and in the regulation of cytokines production according to the type of received signals respectively. The review has been made about the role of mTOR in macrophages' reprogramming, in particular tumor-associated ones. The PubMed resource is used for information search

1. Katholnig К, Linke M, Pham H,etal. Immune responses of macrophagesand dendritic cells regulated by mTOR signaling. Biochemical Society Transactions 2013; 41 (4): 927-33.
2. Crisan TO, Netea MG, Joosten LA. Innate immune memory: Implications for host responses to damage-associated molecular patterns. European Journal of Immunology 2016; 46 (4): 817-28.
3. Luca C, Fragkogianni S, Sims AH, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell 2019; 35 (4): 588-602.
4. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012; 149 (2): 274-93.
5. Covarrubias AJ, Aksoylar HI, Horng T. Control of macrophage metabolism and activation by mTOR and Akt signaling. Seminars in Immunology 2015; 27 (4): 286-96.
6. Abdalla AE, Li Q, Xie L, et al. Biology of IL-27 and its Role in the Host Immunity against Mycobacterium Tuberculosis. International Journal Biological Sciences 2015; 11 (2): 168-75.
7. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. The Journal of Clinical Investigation 2012; 122(3)787-95.
8. Biswas SK. Metabolic Reprogramming of Immune Cells in Cancer Progression. Immunity 2015;43: 435-49.
9. Krausgruber T, Blazek K, Smallie T, et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nature Immunology 2011; 12 (3): 231-8.
10. Jenkins SJ, Ruckerl D, Thomas GD, et al. IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. The Journal of Experimental Medicine 2013; 210 (11): 2477-91.
11. Odegaard Jl, Ricardo-Gonzalez RR, Goforth MH, et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007; 447(7148): 1116-20.
12. Mantovani A, Marchesi F, Malesci A, et al. Tumor-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 2017; 14: 399-416.
13. Allavena P, Mantovani A. Immunology in the clinic review series; focus on cancer: Tumor-associated macrophages: Undisputed stars of the inflammatory tumor microenvironment. Clin Exp Immunol 2012; 167: 195-205.
14. Zumsteg A, Christofori G. Corrupt policemen: Inflammatory cells promote tumor angiogenesis. Curr Opin Oncol 2009; 21: 60-70.
15. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 2011 Oct25;11 (11): 750-61.
16. R. Ostuni F, Kratochvill PJ, Murray, et al. Macrophages and cancer: from mechanisms to therapeutic implications. Trends in Immunology 2015; 36 (4): 229-39.
17. Mercalli A, Caiavita I, Dugnani E, et al. Rapamycin unbalances the polarization of human macrophages to M1. Immunology 2013; 140(2): 179-90.
18. Sengupta S, Peterson TR, Sabatini DM. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Molecular Cell 2010; 40 (2): 310-22.
19. Schmitz F, HeitA, Dreher S, et al. Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. The European Journal of Immunology 2008; 38 (11): 2981-92.
20. Chen H, Cowan MJ, Hasday JD, et al. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. Journal of Immunology 2007; (179): 6097-106.
21. Hedl M, Abraham О Secretory Mediators Regulate Nod2-lnduced Tolerance in Human Macrophages. Gastroenterology 2011; 140 (1): 231-41.
22. Wang Z, Zhou S, Sun C, et al. Interferon-y inhibits nonopsonized phagocytosis of macrophages via an mTORCI-c/EBPp pathway. Journal of Innate Immunity 2015; 7 (2): 165-76.
23. Sharma G, Dutta RK, Khan MA, et al. IL-27 inhibits IFN-y induced autophagy by concomitant induction of JAK/PI3 K/Akt/mTOR cascade and up-regulation of Mcl-1 in Mycobacterium tuberculosis H37Rv infected macrophages. International Journal of Biochemistry & Cell Biology 2014; (55): 335-47.
24. Bosmann M, Haggadone MD, Hemmila MR, et al. Complement activation product C5a is a selective suppressor of TLR4-induced, but not TLR3-induced, production of IL-27 (p28) from macrophages. Journal of Immunology 2012; 188 (10): 5086-93.
25. Ding A, Hongfeng J, Westerterp M, et al. Disruption of mTORCI in Macrophages Decreases Chemokine Gene Expression and Atherosclerosis. Circulation Research 2014; 114 (10): 1576-84.
26. Naugler WE, Karin M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends in Molecular Medicine 2008; 14 (3): 109-19.
27. Goncharova EA, Goncharov DA, Damera G, et al. Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of tsc2-deficient cells: Relevance to pulmonary lymphangioleiomyomatosis. Molecular Pharmacology 2009 (76): 766-77.
28. Schroer N, Pahne J, Walch B, et al. Molecular pathobiology of human cervical high-grade lesions: Paracrine stat3 activation in tumor-instructed myeloid cells drives local mmp-9 expression. Cancer Research 2011; (71): 87-97.
29. Dyken van SJ, Locksley RM. lnterleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol 2013; 31: 317-43.
30. Hudson CC, Liu M, Chiang GG, et al. Regulation of hypoxia-inducible factor 1 alpha expression and function by the mammalian target of rapamycin. Molecular Cell Biology 2002; 22 (20): 7004-14.
31. Kim SY, Choi YJ, Joung SM, et al. Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor. Immunology 2010; 129 (4): 516-24.
32. WengerRH. Cellularadaptationto hypoxia: 02-sensing protein hydroxylases, hypoxia-inducible transcription factors, and 02-regulated gene expression. The FASEB Journal 2002; 16 (10): 1151-62.
33. Semenza GL. Targeting hif-1 for cancer therapy. National Reviews. Cancer 2003; (3): 721-32.
34. Csibi A, et al. The mTORCI/S6K1 pathway regulates glutamine metabolism through the elF4B-dependent control of c-Myc translation. Current biology 2014; 24 (19): 2274-80.
35. Sears R, Nuckolls F, Haura E, et al. Multiple Ras-dependent phosphorylation pathways regulate Мус protein stability. Genes & Development 2000; 14 (19): 2501-14.
36. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. Journal of Immunology 2006; 177 (10): 7303-11.
37. Xu X, Grijalva A, Skowronski A, et al. Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metabolism 2013; (18): 816-30.
38. Liu H, Ma Y, Cole SM, et al. Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival. Blood 2003; 102 (1): 344-52.
39. Philip B, Ito K, Moreno-Sanchez R, etal. HIF expression and the role of hypoxic microenvironments within primary tumors as protective sites driving cancer stem cell renewal and metastatic progression. Carcinogenesis 2013; 34 (8): 1699-707.
40. Muraoka-Cook RS, Kurokawa H, Koh Y, et al. Conditional overexpression of active transforming growth factor betal in vivo accelerates metastases of transgenic mammary tumors. Cancer Research 2004; 64 (24): 9002-11.
41. Chen W, Ma T, Shen X, et al. Macrophage-lnduced Tumor Angiogenesis Is Regulated by the TSC2 — mTOR Pathway. Cancer Research 2012; (72): 1363.
42. Ma J, Meng Y, Kwiatkowski DJ, et al. Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. The Journal of Clinical Investigation 2010; (120): 103-14.
43. Sumimoto H, Imabayashi F, Iwata T, et al. The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells. The Journal of Experimental Medicine 2006; (203): 1651-6.
44. Cannon MJ, Ghosh D, Gujja S. Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated Macrophages. Vaccines (Basel) 2015; 3 (2): 448-66.
45. Bosch van den MW M, Palsson-Mcdermott E, Johnson DS, et al. LPS Induces the Degradation of Programmed Cell Death Protein 4 (PDCD4) to Release Twist2, activating c-Maf Transcription to Promote lnterleukin-10 Production. The Journal of Biological Chemistry 2014; (289): 22980-90.
46. Kujawski M, Kortylewski M, Lee H, et al. Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. The Journal of Clinical Investigation 2008; 118 (10): 3367-77.
47. Foekens JA, Peters HA, Look, et al. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Cancer Res 2000; (60): 636-43.
48. Bonde AK, Tischler V, Kumar S. Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors. ВМС Cancer 2012; (12): 35.
49. Thomas DA, Massague J. TGF-p directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 2005; (8): 369-80.
50. Sica A, Melillo G, Varesio L. Hypoxia: A double-edged sword of immunity. J Mol Med 2011; (89): 657-65.

2020_01_115-121.pdf602.97 KB

No votes yet